Q1 Earnings Forecast for Arvinas Issued By Leerink Partnrs
Analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of Arvinas in a research report issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens ...
Q1 EPS Forecast for CRISPR Therapeutics Decreased by Analyst
Zacks Research decreased their Q1 2025 EPS estimates for CRISPR Therapeutics in a report issued on Wednesday, February 5th. Zacks Research analyst R. Department now anticipates that the company will ...
Fortrea Target of Unusually Large Options Trading (NASDAQ:FTRE)
Fortrea Holdings Inc. (NASDAQ:FTRE – Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Stock investors bought 5,472 put options on the stock. This represents ...
Mizuho Downgrades Kraft Heinz (NASDAQ:KHC) to Neutral
Kraft Heinz (NASDAQ:KHC – Get Free Report) was downgraded by stock analysts at Mizuho from an “outperform” rating to a “neutral” rating in a report issued on Monday, Marketbeat reports. They currently ...
Stock Buyback Program Authorized by Harmonic (NASDAQ:HLIT) Board
Harmonic (NASDAQ:HLIT – Get Free Report) declared that its board has initiated a stock repurchase plan on Monday, February ...
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives $42.86 Average PT from Brokerages
Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Get Free Report) have been given a consensus recommendation of ...
Twist Bioscience approves stock increase, officer exculpation
Twist Bioscience Corporation (NASDAQ:TWST), a synthetic DNA specialist with a market capitalization of $2.8 billion, recently held its Annual Meeting of Stockholders, resulting in significant ...
JFrog CEO Shlomi Ben Haim sells shares worth $652,875
JFrog Ltd (NASDAQ:FROG), a software company with impressive gross profit margins of 78% and strong financial health according to InvestingPro, reported that CEO Shlomi Ben Haim recently sold 17,775 ...
Victory Capital reports $176.5 billion in AUM
SAN ANTONIO - Victory Capital Holdings, Inc. (NASDAQ: NASDAQ:VCTR), a global asset management firm, has announced its latest figures for Assets Under Management (AUM), reporting a total of $176.5 ...
Twist Bioscience director Robert Chess sells shares totaling $156,216
Robert Chess, a director at Twist Bioscience Corp (NASDAQ:TWST), a $2.8 billion market cap biotechnology company with a Fair overall financial health rating according to InvestingPro, recently sold 2, ...
10X Genomics stock plunges to 52-week low of $11.89
In a stark reflection of the challenges facing the biotech sector, 10X Genomics Inc (NASDAQ:TXG) stock has tumbled to a 52-week low, touching down at $11.89. According to InvestingPro data, technical ...